| SSP034 Combisal® 125mcg/25mcg inhalers (PDF:146KB) |
22 Jul 2022 to 19 Aug 2022 |
Combisal® 125mcg/25mcg inhalers supporting guidance plus Q&A (PDF:153KB) |
| SSP033 Paracetamol 120mg suppositories (PDF:139KB) |
31 May 2022 to 26 Aug 2022 |
Paracetamol 120mg suppositories supporting guidance plus Q&A (PDF:111KB) |
| SSP032 Atorvastatin (Lipitor®) 10mg chewable tablets (PDF:145KB) |
31 May 2022 to 12 Aug 2022 |
Atorvastatin (Lipitor®) 10mg chewable tablets supporting guidance plus Q&A (PDF:117KB) |
| SSP031 Estradiol (Sandrena®) 0.5mg and 1mg gel sachets substitution and restriction (PDF:751KB) |
19 May 2022 to 19 Aug 2022
This SSP has been varied – the revised date is now 28 October 2022
|
Sandrena® supporting guidance plus Q&A (PDF:185KB) |
| SSP030 Estradiol (Sandrena®) 0.5mg and 1mg gel sachets substitution (PDF:751KB) |
19 May 2022 to 19 Aug 2022
This SSP has been varied – the revised date is now 28 October 2022
|
Sandrena® supporting guidance plus Q&A (PDF:183KB) |
| SSP029 Estradiol (Sandrena®) 0.5mg and 1mg gel sachets restriction (PDF:600KB) |
19 May 2022 to 19 Aug 2022
This SSP has been varied – the revised date is now 28 October 2022
|
Sandrena® supporting guidance plus Q&A (PDF:130KB) |
| SSP028 Estradiol (Lenzetto®)1.53mg/dose transdermal spray substitution and restriction (PDF:749KB) |
19 May 2022 to 19 Aug 2022
This SSP has been varied – the revised date is now 28 October 2022
|
Lenzetto® supporting guidance plus Q&A (PDF:147KB) |
| SSP027 Estradiol (Lenzetto®)1.53mg/dose transdermal spray substitution (PDF:748KB) |
19 May 2022 to 19 Aug 2022
This SSP has been varied – the revised date is now 28 October 2022
|
Lenzetto® supporting guidance plus Q&A (PDF:146KB) |
| SSP026 Estradiol (Lenzetto®)1.53mg/dose transdermal spray restriction (PDF:601KB) |
19 May 2022 to 19 Aug 2022
This SSP has been varied – the revised date is now 28 October 2022
|
Lenzetto® supporting guidance plus Q&A (PDF:128KB) |
| SSP025 Estriol (Ovestin® 1mg cream) 0.1% cream substitution and restriction (PDF:228KB) |
19 May 2022 to 19 Aug 2022
This SSP has been varied – the revised date is now 28 October 2022
Please note that the dose equivalence advice and endorsement guidance for this SSP have been updated, 28/7/22
|
Ovestin® supporting guidance plus Q&A (PDF:152KB) |
| SSP024 Estriol (Ovestin® 1mg cream) 0.1% cream substitution (PDF:226KB) |
19 May 2022 to 19 Aug 2022
This SSP has been varied – the revised date is now 28 October 2022
Please note that the dose equivalence advice and endorsement guidance for this SSP have been updated, 28/7/22
|
Ovestin® supporting guidance plus Q&A (PDF:133KB) |
| SSP023 Estradiol (Oestrogel® Pump-Pack 0.06% gel) 0.06% gel (750microgram per actuation) substitution and restriction (PDF:751KB) |
19 May 2022 to 19 Aug 2022
This SSP has been varied – the revised date is now 28 October 2022
|
Oestrogel® supporting guidance plus Q&A (PDF:150KB) |
| SSP022 Estradiol (Oestrogel® Pump-Pack 0.06% gel) 0.06% gel (750microgram per actuation) substitution (PDF:750KB) |
19 May 2022 to 19 Aug 2022
This SSP has been varied – the revised date is now 28 October 2022
|
Oestrogel® supporting guidance plus Q&A (PDF:149KB) |
| SSP020 Ovestin® 1mg cream restriction (PDF:166KB) |
29 Apr 2022 to 29 Jul 2022
This SSP has been varied – the revised date is now 28 October 2022
|
Ovestin® supporting guidance plus Q&A (PDF:122KB) |
| SSP019 Oestrogel® Pump-Pack 0.06% gel restriction (PDF:167KB) |
29 Apr 2022 to 29 Jul 2022
This SSP has been varied – the revised date is now 28 October 2022
|
Oestrogel® supporting guidance plus Q&A (PDF:125KB) |
| SSP005 Fluoxetine 10mg tablets (PDF:134KB) |
12 Mar 2020 to 31 Mar 2021
This SSP has been varied – the revised end date is now 12 August 2022
Please note that from 1 Feb 2022 for endorsement purposes the reference number of this SSP has been changed to SSP 005 to reflect updated guidance
|
Fluoxetine supporting guidance plus Q&A (PDF: 107KB) |
